Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
Vericel Corporation (NASDAQ:VCEL), a specialist in advanced therapies for sports medicine and severe burn care, will participate in a fireside chat at the Wells Fargo Healthcare Conference. The presentation is scheduled for September 4, 2025, at 3:45 p.m. ET. Investors can access the webcast through Vericel's investor relations website at investors.vcel.com.
Vericel Corporation (NASDAQ:VCEL), specialista in terapie avanzate per la medicina sportiva e la cura delle gravi ustioni, parteciperà a un fireside chat al Wells Fargo Healthcare Conference. La presentazione è programmata per il 4 settembre 2025 alle 15:45 ET. Gli investitori potranno seguire il webcast tramite il sito delle relazioni con gli investitori di Vericel all'indirizzo investors.vcel.com.
Vericel Corporation (NASDAQ:VCEL), especialista en terapias avanzadas para medicina deportiva y atención de quemaduras graves, participará en un fireside chat en el Wells Fargo Healthcare Conference. La presentación está programada para el 4 de septiembre de 2025 a las 3:45 p.m. ET. Los inversores pueden acceder al webcast a través del sitio de relaciones con inversores de Vericel en investors.vcel.com.
Vericel Corporation (NASDAQ:VCEL)은 스포츠 의학 및 중증 화상 치료를 위한 첨단 치료제 전문 기업으로서 Wells Fargo Healthcare Conference의 파이어사이드 채팅에 참여합니다. 발표는 2025년 9월 4일 오후 3시 45분(미국 동부시간)에 예정되어 있습니다. 투자자들은 Vericel 투자자 관계 웹사이트 investors.vcel.com을 통해 웹캐스트를 시청할 수 있습니다.
Vericel Corporation (NASDAQ:VCEL), spécialiste des thérapies avancées en médecine du sport et du soin des brûlures sévères, participera à un fireside chat lors de la Wells Fargo Healthcare Conference. La présentation est prévue le 4 septembre 2025 à 15h45 (heure de l'Est). Les investisseurs peuvent accéder au webcast via le site des relations investisseurs de Vericel à investors.vcel.com.
Vericel Corporation (NASDAQ:VCEL), ein Spezialist für fortschrittliche Therapien in der Sportmedizin und der Versorgung schwerer Verbrennungen, wird an einem Fireside Chat auf der Wells Fargo Healthcare Conference teilnehmen. Die Präsentation ist für den 4. September 2025 um 15:45 Uhr ET angesetzt. Anleger können das Webcast über die Investor-Relations-Website von Vericel unter investors.vcel.com verfolgen.
- None.
- None.
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Wells Fargo Healthcare Conference at 3:45 p.m. ET on Thursday, September 4, 2025.
A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com.
About Vericel Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. Vericel markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to
Epicel® and MACI® are registered trademarks of Vericel Corporation. NexoBrid® is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. © 2025 Vericel Corporation. All rights reserved.
Investor Contact:
Eric Burns
ir@vcel.com
+1 (734) 418-4411
FAQ
When is Vericel (NASDAQ:VCEL) presenting at the Wells Fargo Healthcare Conference?
How can investors access Vericel's Wells Fargo Healthcare Conference presentation?
What markets does Vericel Corporation (NASDAQ:VCEL) operate in?
What type of presentation will Vericel give at the Wells Fargo conference?
